Analyst stock forecast
Neumora Therapeutics, Inc. Forecast: $6.28 Analyst Target
NMRA has a $6.28 target, Buy rating and 8 analysts. As of 2026-08-16.
Direct answer
Neumora Therapeutics, Inc.'s average price target is $6.28.
The target implies +292.7% from the recorded current price, and the consensus rating is Buy.
The low target implies +87.5%, the high target implies +775%, and the range spans 687.5% of the current price.
Forecast evidence checked August 16, 2026.
Get free Neumora Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.60
- Average price target
- $6.28
- High price target
- $14.00
- Low price target
- $3.00
- Low target gap
- +87.5%
- Target upside
- +292.7%
- High target gap
- +775%
- Target range width
- 687.5%
- Consensus rating
- Buy
- Analysts
- 8
- Evidence date
- August 16, 2026
- Valid through
- August 23, 2026
Explore related company data
Read the frequently asked questions.
What is Neumora Therapeutics, Inc.'s average price target?
Neumora Therapeutics, Inc.'s verified average price target is $6.28. The target range is $3.00 to $14.00.
How far are Neumora Therapeutics, Inc.'s low and high targets from the recorded price?
The low target implies +87.5%, while the high target implies +775%.
How many analysts are included in Neumora Therapeutics, Inc.'s consensus?
The verified consensus includes 8 analysts.
How is Neumora Therapeutics, Inc.'s target upside or downside calculated?
The average target of $6.28 is divided by the recorded price of $1.60, then one is subtracted to produce +292.7%. This does not guarantee a future return.
When was Neumora Therapeutics, Inc.'s analyst forecast verified?
The data was verified on 2026-08-16. The dataset is valid through 2026-08-23.